Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001169232-03-005850
Filing Date
2003-09-29
Accepted
2003-09-29 16:40:42
Documents
10
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d57002_10k.txt 10-K 375615
3 MATERIAL CONTRACTS d57002_ex10-8.txt EX-10.8 10023
4 MATERIAL CONTRACTS d57002_ex10-22.txt EX-10.22 4759
5 STATEMENT RE: COMPUTATION OF RATIOS d57002_ex12-1.txt EX-12.1 2028
6 SUBSIDIARIES OF THE REGISTRANT d57002_ex21-0.txt EX-21.0 689
7 CONSENTS OF EXPERTS AND COUNSEL d57002_ex23-0.txt EX-23.0 1043
8 CERTIFICATIONS REQUIRED UNDER SECTION 302 d57002_ex31-1.txt EX-31.1 4010
9 CERTIFICATIONS REQUIRED UNDER SECTION 302 d57002_ex31-2.txt EX-31.2 4017
10 CERTIFICATIONS REQUIRED UNDER SECTION 906 d57002_ex32-1.txt EX-32.1 1404
11 CERTIFICATIONS REQUIRED UNDER SECTION 906 d57002_ex32-2.txt EX-32.2 1413
  Complete submission text file 0001169232-03-005850.txt   407960
Mailing Address C/O DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 7329804500
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-12957 | Film No.: 03915358
SIC: 2836 Biological Products, (No Diagnostic Substances)